Physician profile
Oleg Kovalenko
NPI 1205082393
$1,358.60
in general payments reported to CMS, 2019-2025
8 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.62 · 2022: $218 · 2024: $963 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $779 · Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $779.22 |
| Food and Beverage | $322.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,007.25 | 2024-2025 | Emblem Mri S-Icd, Bodyguardian, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $241.45 | 2022-2025 | Ensite Precision, Amplatzer Piccolo, Amplatzer |
| Ethicon US, LLC | $23.70 | 2022 | |
| Bardy Diagnostics, INC. | $19.44 | 2019 | |
| B. Braun Interventional Systems INC. | $19.18 | 2019 | |
| Merck Sharp & Dohme LLC | $16.65 | 2024 | Gardasil, Gardasil 9, M-M-R II |
| Cranial Technologies, INC | $16.30 | 2022 | |
| Sanofi Pasteur INC. | $14.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oleg Kovalenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.